NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.



Don't have an account? Register

ADVERTISEMENT

ADVERTISEMENT

Plan to expand membership of obesity group

By David Lynch - 19th Jul 2022

obesity

Expansion of the membership of the obesity policy implementation oversight group (OPIOG), to include patient representatives, is being considered. 

Discussions were held last year regarding an expansion of membership of the OPIOG, but no such action has yet been taken. It was envisioned that an expansion would include the addition of service users and patient representatives. 

A Department of Health spokesperson told the Medical Independent that this plan had not as yet been progressed. “However, the issue of whether there will be additional representation on the group, and who might be included, will be considered at a future date”. 

The spokesperson added that the Department had recently received “a final draft” of the evaluation of the Obesity Policy and Action Plan (OPAP), which was conducted by the Centre for Health and Diet Research, University College Cork. 

This evaluation will “inform” an upcoming mid-term review of the OPAP. 

The review is said to provide the opportunity to “consider developments and new evidence since the publication of the OPAP, and to assess which elements might best be further progressed by legislation or by other means”. 

“It is intended that both the evaluation and the review will be published.” 

The Department also stated that the review of the OPAP will feed into the Government’s work on the proposed Public Health Obesity Bill. 

“The OPAP provides for a mid-term review to be carried out, which provides the opportunity to consider developments and new evidence since the publication of the OPAP, and to assess which elements might best be further progressed by legislation or by other means,” Minister of State with responsibility for Public Health, Well Being and National Drugs Strategy, Mr Frank Feighan, told the Dáil in late April. 

Leave a Reply

ADVERTISEMENT

Latest

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Latest Issue
Medical Independent 5th November
Medical Independent 5th November 2024

You need to be logged in to access this content. Please login or sign up using the links below.

ADVERTISEMENT

Trending Articles

ADVERTISEMENT